[Prothanon eyedrops. 2. Results of clinical test in double-blind experiment].
D002986:Clinical Trials as Topic; D003231:Conjunctivitis / Q000188:drug therapy*; D004342:Drug Hypersensitivity / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D009278:Naphazoline / Q000627:therapeutic use; D009281:Naphthalenes / Q000627:therapeutic use; D014663:Nasal Decongestants / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D011398:Promethazine / Q000009:adverse effects / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy
D007093:Imidazoles; D009281:Naphthalenes; D014663:Nasal Decongestants; D009883:Ophthalmic Solutions; D011398:Promethazine; D009278:Naphazoline
Uber Prothanon-Augentropfen. 2. Ergebnisse klinischer Prüfung im doppelten Blindversuch.